|
|
|
|
Major Pharmaceutical Preparations Industry Profitability
Profitability Information & Trends 
Industry: Major Pharmaceutical Preparations ▼
|
Category:
|
|
Period:
|
|
|
|
Major Pharmaceutical Preparations ▼
|
| Major Pharmaceutical Preparations Industry Profitability Ratios |
2 Q 2024 |
1 Q 2024 |
0 Q 2024 |
4 Q 2023 |
3 Q 2023 |
|
|
2024 |
2024 |
2024 |
2023 |
2023 |
| Gross Margin |
71.65 % |
70.01 % |
82.39 % |
69.11 % |
64.53 % |
| Gross Margin Annual (TTM) |
67.6 % |
66.97 % |
73.37 % |
68.29 % |
68.24 % |
| Gross Margin Ranking |
# 23 |
# 20 |
# 13 |
# 27 |
# 22 |
| EBITDA Margin |
24.02 % |
13.96 % |
13.89 % |
11.62 % |
19.17 % |
| EBITDA Margin Annual (TTM) |
20.74 % |
17.9 % |
16.62 % |
15.46 % |
20.35 % |
| EBITDA Margin Ranking |
# 22 |
# 59 |
# 36 |
# 41 |
# 49 |
| Operating Margin |
16.25 % |
8.26 % |
13.66 % |
11.46 % |
11.04 % |
| Operating Margin Annual (TTM) |
11.01 % |
8.87 % |
14.64 % |
13.63 % |
16.06 % |
| Operating Margin Ranking |
# 42 |
# 68 |
# 47 |
# 58 |
# 71 |
| Pre-Tax Margin |
12.68 % |
4.5 % |
11.38 % |
9.54 % |
6.53 % |
| Pre-Tax Margin Annual (TTM) |
8.74 % |
6.89 % |
9.94 % |
9.25 % |
8.59 % |
| Pre-Tax Margin Ranking |
# 36 |
# 81 |
# 37 |
# 64 |
# 68 |
| Net Margin |
9.45 % |
2.51 % |
15.47 % |
12.97 % |
22.73 % |
| Net Margin Annual (TTM) |
11.73 % |
9.68 % |
13.76 % |
12.81 % |
10.56 % |
| Net Margin Ranking |
# 42 |
# 86 |
# 19 |
# 9 |
# 85 |
Comment on the 2 Q 2024 Gross Margin within the Major Pharmaceutical Preparations Industry |
Major Pharmaceutical Preparations Industry Gross Profits grew by 6.21 % in 2 Q 2024 sequentially, while Revenue increased by 5.8 %, this led to improvement in Major Pharmaceutical Preparations Industry's Gross Margin to 70.41 %, above Major Pharmaceutical Preparations Industry average Gross Margin.
On the trailing twelve months basis gross margin in 2 Q 2024 grew to 67.6 %.
Within Healthcare sector only one Industry has achieved higher gross margin. Gross margin total ranking has deteriorated compare to previous quarter from 20 to 23. |
Note, Numbers include only companies who have reported earnings results. Numbers change as more businesses report financial results. See the full List.
| Gross Margin Statistics |
| High |
Average |
Low |
| 75.17 % |
68.64 % |
60.59 % |
| 0. quarter 2024 |
|
4. quarter 2018 |
| Gross Margin Industry Ranking |
| Within: |
No. |
| Healthcare Sector |
# 2 |
| Overall |
# 23
|
Major Pharmaceutical Preparations Industry EBITDA Margin Statistics
|
|
|
|
|
| EBITDA Margin Statistics |
| High |
Average |
Low |
| 36.08 % |
23.24 % |
3.36 % |
| 4. quarter 2014 |
|
2. quarter 2015 |
| EBITDA Margin Industry Ranking |
| Within: |
No. |
| Healthcare Sector |
# 2 |
| Overall |
# 22
|
EBITDA Margin Comment on the 2 Q 2024 within the Major Pharmaceutical Preparations Industry |
Major Pharmaceutical Preparations Industry Ebitda grew by 42.6 % in 2 Q 2024 sequentially, while Revenue increased by 5.8 %, this led to improvement in Major Pharmaceutical Preparations Industry's Ebitda Margin to 24.02 %, above Major Pharmaceutical Preparations Industry average Ebitda Margin.
On the trailing twelve months basis Ebitda Margin in 2 Q 2024 grew to 20.74 %.
Within Healthcare sector only one Industry has achieved higher Ebitda Margin. Ebitda margin total ranking has impoved so far to 22, from total ranking in previous quarter at 59. |
|
Major Pharmaceutical Preparations Industry Operating Margin
Statistics |
|
|
Operating Margin Comment on the 2 Q 2024 within the Major Pharmaceutical Preparations Industry |
Major Pharmaceutical Preparations Industry Operating Profit grew by 82.62 % in 2 Q 2024 sequentially, while Revenue increased by 5.8 %, this led to improvement in Major Pharmaceutical Preparations Industry's Operating Margin to 16.25 %, Operating Margin remained below Major Pharmaceutical Preparations Industry average.
On the trailing twelve months basis operating margin in 2 Q 2024 grew to 11.01 %.
Within Healthcare sector, Major Pharmaceutical Preparations Industry achieved highest operating margin. Operating margin total ranking has impoved so far to 42, from total ranking in previous quarter at 68. |
| Operating Margin Statistics |
| High |
Average |
Low |
| 27.65 % |
16.72 % |
-1.98 % |
| 3. quarter 2019 |
|
4. quarter 2017 |
| Operating Margin Industry Ranking |
| Within: |
No. |
| Healthcare Sector |
# 1 |
| Overall |
# 42
|
|
|
Major Pharmaceutical Preparations Industry Pre-Tax Margin Statistics
|
|
|
|
|
| Pre-Tax Margin Statistics |
| High |
Average |
Low |
| 27.7 % |
14.81 % |
-1.89 % |
| 4. quarter 2014 |
|
4. quarter 2017 |
Comment on the 2 Q 2024 Pre-Tax Margin in the Major Pharmaceutical Preparations Industry |
Major Pharmaceutical Preparations Industry Pre-Tax Income grew by 134.15 % in 2 Q 2024 sequentially, while Revenue increased by 5.8 %, this led to improvement in Major Pharmaceutical Preparations Industry's Pre-Tax Margin to 12.68 %, Pre-Tax Margin remained below Major Pharmaceutical Preparations Industry average.
On the trailing twelve months basis Pre-Tax Margin in 2 Q 2024 grew to 8.74 %.
Within Healthcare sector, Major Pharmaceutical Preparations Industry achieved highest Pre-Tax Margin. Pre-Tax Margin total ranking has impoved so far to 36, from total ranking in previous quarter at 81. |
| Pre-Tax Margin Industry Ranking |
| Within: |
No. |
| Healthcare Sector |
# 1 |
| Overall |
# 36
|
|
Major Pharmaceutical Preparations Industry Net Margin Statistics |
|
|
|
Net Margin Comment on the 2 Q 2024 in the Major Pharmaceutical Preparations Industry |
Major Pharmaceutical Preparations Industry Net Profit grew by 236.55 % in 2 Q 2024 sequentially, while Revenue increased by 5.8 %, this led to improvement in Major Pharmaceutical Preparations Industry's Net Margin to 9.45 %, Net Margin remained below Major Pharmaceutical Preparations Industry average.
On the trailing twelve months basis Net margin in 2 Q 2024 grew to 11.73 %.
Within Healthcare sector, Major Pharmaceutical Preparations Industry achieved highest Net margin. Net margin total ranking has impoved so far to 42, from total ranking in previous quarter at 86. |
| Net Margin Statistics |
| High |
Average |
Low |
| 22.73 % |
12.35 % |
-17.68 % |
| 3. quarter 2023 |
|
4. quarter 2017 |
| Net
Margin Industry Ranking |
| Within: |
No. |
| Healthcare Sector |
# 1 |
| Overall |
# 42
|
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
